GLP-1 access is shifting – Are stakeholders ready?
CRA’s Becky Davis examines how these dramatic price reductions, combined with Direct-to-Patient distribution models, may be accelerating employer migration...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Evaluating unintended impacts of the IRA’s Medicare Drug Price Negotiation Program on small and large molecule medicinesA leading pharmaceutical company sought support from CRA Life Sciences experts in analyzing the patient, health system, and innovation implications of the IRA'sView engagement
- 02Developing an evidence-based framework for sustainable NCCP funding and address global disparities in implementation and outcomesA leading pharmaceutical company sought CRA Life Sciences experts to gain a deeper understanding of how governments plan and finance national cancer strategiesView engagement
- 03Mapping and assessing national impacts of JCAs across EuropeCRA Life Science experts were retained by a client to provide support on the impact of the EU HTA regulation and the associated JCAs on national HTA systems.View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsUpcoming events
ISPOR Europe 2025
Abhishek Kumar, Elaine Damato and Alice Kim present their poster titled “Staying Competitive in a Crowded Vaccines Market: Is There Room for a Third or Fourth...
16th CAM Annual Conference
Greg Bell is a panelist during the session titled “Navigating Life Sciences disputes. An arbitrator’s perspective.” For more information on this event, click...
Recent events
IP Watchdog: 4th Annual Life Sciences Masters™ 2025
CRA is a proud sponsor of the conference focusing on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law,...
World Orphan Drug Congress EU 2025
CRA is a proud sponsor of the the largest and most established orphan drug & rare disease meeting of its kind across the globe. From cell and gene therapy,...